DNA
Price
$11.97
Change
+$1.51 (+14.44%)
Updated
Sep 29, 04:59 PM (EDT)
Capitalization
717.85M
48 days until earnings call
Intraday BUY SELL Signals
SEER
Price
$2.15
Change
+$0.12 (+5.91%)
Updated
Sep 29, 04:59 PM (EDT)
Capitalization
105.76M
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DNA vs SEER

DNA vs SEER Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DNA vs. SEER commentary
Sep 29, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNA is a Buy and SEER is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
DNASEER
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend 15 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
COMPARISON
Comparison
Sep 29, 2026
Stock price -- (DNA: $10.46 vs. SEER: $2.03)
Brand notoriety: DNA and SEER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNA: 156% vs. SEER: 143%
Market capitalization -- DNA: $717.85M vs. SEER: $105.76M
DNA [@Biotechnology] is valued at $717.85M. SEER’s [@Biotechnology] market capitalization is $105.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.37B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNA’s FA Score shows that 1 FA rating(s) are green while SEER’s FA Score has 1 green FA rating(s).

  • DNA’s FA Score: 1 green, 4 red.
  • SEER’s FA Score: 1 green, 4 red.
According to our system of comparison, both DNA and SEER are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNA’s TA Score shows that 6 TA indicator(s) are bullish while SEER’s TA Score has 5 bullish TA indicator(s).

  • DNA’s TA Score: 6 bullish, 5 bearish.
  • SEER’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DNA is a better buy in the short-term than SEER.

Price Growth

DNA (@Biotechnology) experienced а +31.08% price change this week, while SEER (@Biotechnology) price change was +9.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.61%. For the same industry, the average monthly price growth was -7.28%, and the average quarterly price growth was +3.82%.

Reported Earning Dates

DNA is expected to report earnings on Nov 16, 2026.

SEER is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (+0.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DNA
Daily Signal:
Gain/Loss:
SEER
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INLF5.230.13
+2.55%
Inlif Ltd
YETI43.331.05
+2.48%
YETI Holdings
GLAS6.850.05
+0.74%
Glass House Brands Inc.
PBHC17.35N/A
N/A
Pathfinder Bancorp
PAAS45.77-2.27
-4.73%
Pan American Silver Corp

DNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNA has been loosely correlated with VCYT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DNA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNA
1D Price
Change %
DNA100%
-1.88%
VCYT - DNA
58%
Loosely correlated
-0.44%
RXRX - DNA
56%
Loosely correlated
-1.07%
TWST - DNA
55%
Loosely correlated
-1.77%
ABSI - DNA
49%
Loosely correlated
-2.57%
SANA - DNA
47%
Loosely correlated
-0.51%
More

SEER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SEER has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SEER jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEER
1D Price
Change %
SEER100%
+6.28%
AXON - SEER
56%
Loosely correlated
-1.25%
ARRY - SEER
47%
Loosely correlated
-4.96%
VCYT - SEER
35%
Loosely correlated
-0.44%
RNA - SEER
35%
Loosely correlated
+1.57%
DNA - SEER
33%
Loosely correlated
-1.88%
More